Lidocaine cytotoxicity to the bovine articular chondrocytes in vitro: changes in cell viability and proteoglycan metabolism. 2011

Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
Department of Orthopaedics and Rehabilitation Medicine, Faculty of Medical Sciences, The University of Fukui, Shimoaizuki 23, Matsuoka, Fukui 910-1193, Japan.

OBJECTIVE A lot of studies on the effect of intra-articular injections are clinical, but many questions on the effect of lidocaine to articular chondrocytes remain unanswered. This study was performed to determine the effects of varying concentrations and exposure times of lidocaine on the viability and proteoglycan metabolism of chondrocytes in vitro. METHODS Cartilage was obtained from metatarsal joints of adult bovines. Chondrocytes in alginate beads were cultured in medium containing 6% fetal calf serum at 370 mOsmol at cell densities of 4 million cells/ml. They were then cultured for 24 h under 21% oxygen with 0.125, 0.25, 0.5, and 1% lidocaine and without lidocaine as control. The cell viability profile across intact beads was determined by manual counting using fluorescent probes and transmission electron microscopy. RESULTS Lactate production was measured enzymatically as a marker of energy metabolism. Glycosaminoglycan (GAG) accumulation was measured using a modified dimethylmethylene blue assay. Cell viability decreased in a time- and dose-dependent manner in the concentration range of 0.125-1.0% lidocaine under the confocal microscope. Under the electron microscope, apoptosis increased as the concentration of lidocaine increased. GAG accumulation/tissue volume decreases as the concentration of lidocaine increased. However, GAG produced per million cells and the rate of lactate production per live cell were significantly higher for cells cultured at 0.5 and 1% lidocaine than the control group. Bovine chondrocytes cultured in alginate beads under high oxygen pressure are negatively influenced by increasing concentrations of lidocaine. CONCLUSIONS Cell viability and proteoglycan production (GAG accumulation/tissue volume) decreased as the concentration of lidocaine increased. These data suggest caution in prolonged exposure of cartilage to high concentration lidocaine. Repeated joint injection of lidocaine potentially worsens osteoarthrosis by accelerating cartilage degradation.

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D008684 Metatarsus The part of the foot between the tarsa and the TOES.
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002358 Cartilage, Articular A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact. Articular Cartilage,Articular Cartilages,Cartilages, Articular
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D000779 Anesthetics, Local Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. Anesthetics, Conduction-Blocking,Conduction-Blocking Anesthetics,Local Anesthetic,Anesthetics, Topical,Anesthetic, Local,Anesthetics, Conduction Blocking,Conduction Blocking Anesthetics,Local Anesthetics,Topical Anesthetics

Related Publications

Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
January 1988, Connective tissue research,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
January 1992, Connective tissue research,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
October 2007, The American journal of sports medicine,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
January 1997, Research in veterinary science,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
December 1984, Journal of cellular physiology,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
September 1981, Prostaglandins,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
January 1976, Arthritis and rheumatism,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
September 1984, Prostaglandins,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
December 2006, Cell and tissue research,
Tsuyoshi Miyazaki, and Shigeru Kobayashi, and Kenichi Takeno, and Takafumi Yayama, and Adam Meir, and Hisatoshi Baba
March 2018, Journal of orthopaedic trauma,
Copied contents to your clipboard!